# Novo Nordisk raises 2026 outlook as Q3 obesity sales jump 22%

> **Open Intelligence Dossier** · First detected: 2026-11-04 16:00 UTC · Category: Business

## Executive Summary
3 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.

## Intelligence Brief
"Novo Nordisk raises 2026 outlook as Q3 obesity sales jump 22%" is generating significant coverage in the Business category, with 3 articles from 3 distinct sources tracked by PULSE so far.


Outlets currently covering the story include Investor's Business Daily, Fierce Pharma and Financial Times. PULSE measures a story's velocity from how quickly new articles appear and how many independent newsrooms join the coverage.


This brief was generated by PULSE's extractive engine from coverage metadata only. The latest headlines from every source are listed below; the velocity chart shows how the story is developing in real time.

## Multi-Source Evidence Table
| Source Outlet | Headline | Verification URL |
|---|---|---|
| Investor's Business Daily | Novo Surges After Crushing Forecasts On The Back Of Its GLP-1s | [Source Link](https://news.google.com/rss/articles/CBMigAFBVV95cUxOY1RLNmt6NDB1UVpqR0dRdGpsaFFYNkgxUnNzc2V5dzkyeW41T0hnSUVhbkhiMjFVVGhscTB1Y2ZmZXotQmNqTF9xbFExYWE2YldEZjFMQzZyckpuU1V5R3FEUVVTMlZvNDJGQm1kcXU4QVpXWU9GS3hCRDFpX2lWUg?oc=5) |
| Fierce Pharma | Novo catches Wegovy pill tailwind in Q3 as CEO eyes new launch horizons in 2027 | [Source Link](https://news.google.com/rss/articles/CBMiqgFBVV95cUxONVVUOTR2dktfR1g5UURjWVA5emR6VERHNVladEpCRGUya1FTRVFRT0V6ZHFqSDFrU29HeFJtRVF6QmQyQXhOcFozbjAyT2gwRFp4VTgwdzBlSFRCWDU5RjR3b2kxRHdrcDdKaEhUM1B0dEU0SFBfbzZIVndwU3V2d2FOdFdsd2JSVEdFbTFkRXBWUk5tSm51N3FnV3BmenZLRmNkZUNTRG9Wdw?oc=5) |
| Financial Times | Novo sales boosted by Wegovy weight-loss pill | [Source Link](https://news.google.com/rss/articles/CBMihAFBVV95cUxQdHNfZnRMUk5vR0o0RHVmdllwNjN4RXpYMDNNREZzdHhJT3NRd3pkdDI3V3c3OENiMVRHbjdZY2NWMS0tWlJrWUxQRHE1bzFGNGlidHJDZ1VmU2QwN2Uyd2NEeGFwWUJNX1d3aC1MNUNydFFOTHNYSnZybmtBNGFSM1ZzZ0I?oc=5) |

---
*Canonical Source: https://pulse.byoviral.com/trend/2026-11-04/novo-nordisk-raises-2026-outlook-as-q3-obesity-sales-jump-22*